logo
Disturbing reason you feel like you're falling off a cliff right before you nod off

Disturbing reason you feel like you're falling off a cliff right before you nod off

Daily Mail​28-04-2025

Medication taken by some 8 million people in the UK could trigger a frightening sleep disturbance, research has revealed.
Scientists from Saudi Arabia have found that those who take certain antidepressants are at a dramatically increased risk of suffering hypnic jerks—a feeling of a sudden jolt before falling asleep.
The sensation is caused by sudden involuntary muscle contractions that happen during the transitional stage from wakefulness to sleep.
While harmless in most cases, experts have warned the sleep disturbance could lead to insomnia and major depressive disorder.
Now, a neuroscientist has performed an experiment that suggests psychiatric medications can alter chemicals in the brain, leading to hypnic jerks.
In the study, Professor Alghamdi analysed sleep patterns of a middle-aged man who was taking escitalopram — a type of antidepressant called a selective serotonin reuptake inhibitor (SSRI), which are most commonly prescribed to UK patients.
The patient complained of experiencing the sudden falling feeling at night, along with heart palpitations, feeling tense and an excessive fear of not being able to sleep again.
In order to treat the phenomenon, Professor Alghamdi asked the patient to stop taking the SSRI.
Routinely sleeping less than six or seven hours a night demolishes your immune system and significantly raises your risk of developing numerous forms of cancer
After this minor adjustment, the patient showed dramatic improvement in his condition and the hypnic jerk movement completely disappeared at night.
His depressive symptoms, which were being treated with the medicine, also vanished.
Prof Alghamdi hypothesised that the constant sleep disruption had made the patient's depressive symptoms far worse.
'Intensified hypnic jerks can cause chronic sleep deprivation, potentially resulting in depression as a consequence of neurochemical changes in the brain,' he said.
Another study, published in the Indian Journal of Psychiatry, found similar results, further underling the link between SSRIs and the distressing sleep disturbance.
What are antidepressants?
Antidepressants are medicines that treat depression symptoms.
There are around 30 different types that can be prescribed.
The NHS says that most people who have moderate or severe depression notice improvement when they take antidepressants. But it notes that this isn't the case for everyone.
Side effects vary between different people and antidepressants but can include nausea, headaches, a dry mouth and problems having sex.
Antidepressants aren't addictive but patients may have withdrawal symptoms if they stop taking them suddenly or miss a dose.
These can include an upset stomach, flu-like symptoms, anxiety, dizziness and vivid dreams.
Researchers found that when a 31-year-old woman started taking escitalopram she began to experience involuntary head movements whilst sleeping.
These movements abrupt, involuntary spasms which significantly disturbed her quality of sleep.
When she stopped taking escitalopram and started on fluoxetine, another type of SSRI, she reported a significant reduction in the frequency and intensity of the jerky head movements during sleep.
This, researchers concluded, highlights the need for healthcare providers to be aware of this 'potentially overlooked' side effect of SSRIs.
'Hypnic jerks can disrupt sleep, cause anxiety, and negatively impact a patient's quality of life.
'Clinicians should recognise that these involuntary movements, while benign, can be distressing and may arise particularly after dosage increases or initiation of SSRIs', co-author, Dr Simran Sandhu added.
Multiple theories have emerged regarding this mostly harmless phenomena, with experts pointing to stimulants including caffeine and nicotine, to exercise as potential explanations for the jolts.
Some scientists believe that hypnic jerks are caused by the brain misinterpreting the transitional stage between wakefulness and sleep.
The brain 'thinks' that the body should be awake, so sends signals to alert the muscles.
While they can be startling, hypnic jerks are completely harmless, affecting around 70 per cent of adults in the UK, and are rarely a sign of any underlying conditions, experts warn.
It comes as figures show an estimated 8.7million people in England take antidepressants, about one in seven people, with numbers increasing annually.
However, experts have urged caution, with patients advised not to quit taking their medication without talking to the medical professional responsible for their care first.
'Close monitoring of patients, especially those who are newly prescribed SSRIs or have had dosage adjustments, is essential,' Dr Sandhu, co-author of the peer-reviewed study advised.
'Encouraging healthy sleep hygiene practices, including regular sleep schedules and relaxation techniques, can further enhance overall sleep quality and potentially reduce the occurrence of hypnic jerks', he added.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Dentists slam Welsh Government's NHS dental reforms
Dentists slam Welsh Government's NHS dental reforms

South Wales Argus

time2 hours ago

  • South Wales Argus

Dentists slam Welsh Government's NHS dental reforms

The British Dental Association Cymru has warned the Welsh Government that the changes could lead to an exodus from the workforce and should be paused for further trials. The proposed reforms aim to improve oral health, increase prevention, and provide better value for money. However, a survey indicates that only two per cent of dentists believe the changes will support NHS dentistry's sustainability. Just five per cent agree the reforms will enhance prevention, and eight per cent think they will improve access to NHS care. A significant concern is the shift in patient appointments to up to 24 months apart, which could limit early disease detection, including oral cancers. The changes also propose moving patients to a centralised database, potentially fragmenting family care. The reforms are expected to be introduced next year.

Women with genetic cancer risk being ‘missed' due to testing gaps
Women with genetic cancer risk being ‘missed' due to testing gaps

North Wales Chronicle

time3 hours ago

  • North Wales Chronicle

Women with genetic cancer risk being ‘missed' due to testing gaps

A lack of testing for Lynch syndrome also means some cancer patients are unaware of their risk of developing other cancers, academics said. Lynch syndrome is a rare condition which runs in families which puts people at a higher risk of developing cancers of the bowel, womb and ovaries. It is caused by a mutation in the gene that fixes mistakes in DNA when it is copied, which can lead to uncontrolled cell growth. Patients with bowel or womb cancer should have their tumours assessed for markers of Lynch syndrome, according to guidance for the NHS. If these markers are identified, patients should be referred for genetic testing so the diagnosis can be confirmed and they can get support and advice about cancer risk for themselves and their family. A new study by academics at the University of Edinburgh found not all womb cancer patients are being sent for genetic testing. Researchers examined data on 2,500 womb cancer patients across the UK and Ireland between 2022 and 2023. We have launched a Guide to #LynchSyndrome to help provide information and support to anyone who thinks they may have it, that it may run in the family, or have found out they have — The Eve Appeal (@eveappeal) February 13, 2023 They found that 91% of tumours were tested for markers of Lynch syndrome, but the test results were not routinely communicated to the wider clinical team. This means that follow-up genetic counselling and blood tests were not always arranged. Of the 181 participants eligible for genetic counselling, just under two-thirds (64%) were referred for appointments, according to the study, which has been published in the journal BMJ Oncology. Researchers said those who were referred faced long waits, resulting in high dropout rates, meaning only 48% of those eligible went on to get the test. Today's #LynchSyndromeAwarenessDay. Our policy team sat down with our supporter, Jane, to share her experience. As well as highlighting what else needs to be done to improve Lynch syndrome care. Read our blog: — Bowel Cancer UK (@bowelcanceruk) March 22, 2025 Experts from the university said gaps in testing mean some womb cancer patients with Lynch syndrome go undetected. Family members are also left vulnerable to cancer risk, unaware they may have the condition. Dr Neil Ryan, from the University of Edinburgh, who leads the UK audit and research collaborative in obstetrics and gynaecology, said: 'Despite clear guidance and excellent rates of tumour testing, too many women with Lynch syndrome are still being missed because they're not referred for definitive blood testing in a timely way. 'This not only denies them the chance to reduce their future cancer risk but also prevents their relatives from being tested and protected. 'Tumour testing is only cost-effective if it leads to diagnosis — we urgently need to make mainstream testing truly mainstream.'

Women with genetic cancer risk being ‘missed' due to testing gaps
Women with genetic cancer risk being ‘missed' due to testing gaps

Rhyl Journal

time3 hours ago

  • Rhyl Journal

Women with genetic cancer risk being ‘missed' due to testing gaps

A lack of testing for Lynch syndrome also means some cancer patients are unaware of their risk of developing other cancers, academics said. Lynch syndrome is a rare condition which runs in families which puts people at a higher risk of developing cancers of the bowel, womb and ovaries. It is caused by a mutation in the gene that fixes mistakes in DNA when it is copied, which can lead to uncontrolled cell growth. Patients with bowel or womb cancer should have their tumours assessed for markers of Lynch syndrome, according to guidance for the NHS. If these markers are identified, patients should be referred for genetic testing so the diagnosis can be confirmed and they can get support and advice about cancer risk for themselves and their family. A new study by academics at the University of Edinburgh found not all womb cancer patients are being sent for genetic testing. Researchers examined data on 2,500 womb cancer patients across the UK and Ireland between 2022 and 2023. We have launched a Guide to #LynchSyndrome to help provide information and support to anyone who thinks they may have it, that it may run in the family, or have found out they have — The Eve Appeal (@eveappeal) February 13, 2023 They found that 91% of tumours were tested for markers of Lynch syndrome, but the test results were not routinely communicated to the wider clinical team. This means that follow-up genetic counselling and blood tests were not always arranged. Of the 181 participants eligible for genetic counselling, just under two-thirds (64%) were referred for appointments, according to the study, which has been published in the journal BMJ Oncology. Researchers said those who were referred faced long waits, resulting in high dropout rates, meaning only 48% of those eligible went on to get the test. Today's #LynchSyndromeAwarenessDay. Our policy team sat down with our supporter, Jane, to share her experience. As well as highlighting what else needs to be done to improve Lynch syndrome care. Read our blog: — Bowel Cancer UK (@bowelcanceruk) March 22, 2025 Experts from the university said gaps in testing mean some womb cancer patients with Lynch syndrome go undetected. Family members are also left vulnerable to cancer risk, unaware they may have the condition. Dr Neil Ryan, from the University of Edinburgh, who leads the UK audit and research collaborative in obstetrics and gynaecology, said: 'Despite clear guidance and excellent rates of tumour testing, too many women with Lynch syndrome are still being missed because they're not referred for definitive blood testing in a timely way. 'This not only denies them the chance to reduce their future cancer risk but also prevents their relatives from being tested and protected. 'Tumour testing is only cost-effective if it leads to diagnosis — we urgently need to make mainstream testing truly mainstream.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store